The Centers for Medicare & Medicaid Services should develop prior authorization measures for the Medicare Advantage Star Ratings Program to minimize care delays and protect patients from inappropriate care denials, AHA said in comments submitted today. “When instituted appropriately, prior authorization can help align patient care with health plan benefits and facilitates compliance with clinical best practices,” AHA wrote. “However, prior authorization requirements and processes vary widely, even among different health plan products offered by the same issuer, and can create dangerous delays in care delivery when not applied appropriately. They also can create confusion and burden for both patients and providers, leading to additional administrative costs for the health care system.”

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027. CMS…
Chairperson's File
Public
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
Headline
The Centers for Medicare & Medicaid Services released an updated notice Nov. 20 on the processing of Medicare provider claims impacted by the government…
Headline
Dan Peterson, CEO of behavioral health services at Sutter Health, and Matthew White, M.D., chair of the behavioral health service line at Sutter Health, share…
Headline
AHA Executive Vice President Michelle Hood previews the AHA Rural Health Care Leadership Conference — one of the AHA’s flagship events — which will be held Feb…